News & Updates
Filter by Specialty:
Amivantamab-lazertinib bests osimertinib in head-to-head trial on lung cancer
In the phase III MARIPOSA trial, the amivantamab-lazertinib cocktail outdid osimertinib as first-line (1L) treatment for EGFR-mutated, advanced non-small cell lung cancer (NSCLC).
Amivantamab-lazertinib bests osimertinib in head-to-head trial on lung cancer
08 Nov 2023
Women face heightened breast cancer risk from poor air quality
Prolonged exposure to air pollution appears to put women at increased risk of breast cancer, according to data from the French E3N cohort.
Women face heightened breast cancer risk from poor air quality
07 Nov 2023
Placebo effect delivers in open-angle glaucoma
Treatment with placebo is successful in patients with open-angle glaucoma or ocular hypertension, achieving lower intraocular pressure (IOP), compared with untreated control participants, reports a recent study.
Placebo effect delivers in open-angle glaucoma
07 Nov 2023
Diabetes, obesity tied to upstaging in renal cell carcinoma
Diabetes and higher body mass index (BMI) contribute to pathological upstaging in renal cell carcinoma, according to a study. Preoperative tumour size, increased age, and male sex are also significantly associated with upstaging.
Diabetes, obesity tied to upstaging in renal cell carcinoma
07 Nov 2023
Synbiotic supplementation of high-fibre diet promising for weight loss
An open-label, randomized, parallel-design clinical trial demonstrates weight loss as well as decreases in fasting glucose, insulin and insulin resistance in overweight and obese Hong Kong Chinese individuals after high-fibre dietary intervention supplemented with synbiotics.
Synbiotic supplementation of high-fibre diet promising for weight loss
07 Nov 2023
Nirmatrelvir-ritonavir benefits persist against COVID
Management of most adults with COVID-19, particularly those with mild-to-moderate disease, is increasingly occurring in the outpatient setting due to the availability of effective treatment options.
